| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |